This site is intended for healthcare professionals
Drug news

Merck Inc. will not seek approval for Marizev (omarigliptin) in the US or EU for type 2 diabetes management

Read time: 1 mins
Last updated:18th Apr 2016
Published:18th Apr 2016
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest